Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing.

Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH.

PLoS One. 2012;7(4):e34150. doi: 10.1371/journal.pone.0034150.

2.

Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.

Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, Zanovello P.

BMC Genomics. 2013 Aug 29;14:589. doi: 10.1186/1471-2164-14-589.

3.

The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.

Xu L, Li M, Wang M, Yan D, Feng G, An G.

BMC Cancer. 2014 Sep 25;14:714. doi: 10.1186/1471-2407-14-714.

4.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.

Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster B, Schepeler T, Tobiasen H, Thorsen K, Sieber OM, Gibbs P, Lamy P, Hansen TF, Jakobsen A, Riising EM, Helin K, Lubinski J, Hagemann-Madsen R, Laurberg S, Ørntoft TF, Andersen CL.

PLoS One. 2014 Jun 3;9(6):e96767. doi: 10.1371/journal.pone.0096767.

5.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

6.

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M.

Int J Oncol. 2009 Apr;34(4):1069-75.

PMID:
19287964
7.

Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.

Fu J, Tang W, Du P, Wang G, Chen W, Li J, Zhu Y, Gao J, Cui L.

BMC Syst Biol. 2012 Jun 15;6:68. doi: 10.1186/1752-0509-6-68.

8.

MicroRNA expression profiles in human colorectal cancers with liver metastases.

Lin M, Chen W, Huang J, Gao H, Ye Y, Song Z, Shen X.

Oncol Rep. 2011 Mar;25(3):739-47. doi: 10.3892/or.2010.1112.

PMID:
21174058
9.

miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.

Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA.

Mol Cancer Res. 2012 Apr;10(4):504-15. doi: 10.1158/1541-7786.MCR-11-0342.

10.

Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.

Sun G, Cheng YW, Lai L, Huang TC, Wang J, Wu X, Wang Y, Huang Y, Wang J, Zhang K, Hu S, Yang JR, Yen Y.

Oncotarget. 2016 Jan 26;7(4):3857-72. doi: 10.18632/oncotarget.6460.

11.
12.

Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.

Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.

Oncogene. 2012 May 31;31(22):2750-60. doi: 10.1038/onc.2011.453.

PMID:
21963845
13.

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.

Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.

PLoS One. 2015 Oct 1;10(10):e0139233. doi: 10.1371/journal.pone.0139233.

14.

The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.

Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D, Zhou Y.

Int J Oncol. 2014 Jul;45(1):197-208. doi: 10.3892/ijo.2014.2415.

PMID:
24805774
15.

MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer.

Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N.

BMC Cancer. 2010 Apr 29;10:173. doi: 10.1186/1471-2407-10-173.

16.

Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers.

Ninomiya M, Kondo Y, Funayama R, Nagashima T, Kogure T, Kakazu E, Kimura O, Ueno Y, Nakayama K, Shimosegawa T.

PLoS One. 2013 Jun 12;8(6):e66086. doi: 10.1371/journal.pone.0066086.

17.

[Study on miR-490-5p and miR-363 as novel biomarkers for the diagnosis of colorectal cancer].

Xu X, Wu X, Wu S, Jiang Q, Liu H, Chen R, Sun Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Jan;17(1):45-50. Chinese.

PMID:
24519049
18.

Screening miRNAs for early diagnosis of colorectal cancer by small RNA deep sequencing and evaluation in a Chinese patient population.

Wang X, Chen L, Jin H, Wang S, Zhang Y, Tang X, Tang G.

Onco Targets Ther. 2016 Mar 7;9:1159-66. doi: 10.2147/OTT.S100427.

19.

Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types.

Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z.

PLoS One. 2009 Nov 25;4(11):e8003. doi: 10.1371/journal.pone.0008003.

20.

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.

Zhao L, Sun Y, Hou Y, Peng Q, Wang L, Luo H, Tang X, Zeng Z, Liu M.

Int J Biochem Cell Biol. 2012 Nov;44(11):2051-9. doi: 10.1016/j.biocel.2012.08.005.

PMID:
22964023
Items per page

Supplemental Content

Support Center